S2s Surgical Llc - Providence Business News

Home Tags S2s Surgical Llc

TEAM MEETING: From left, Brenton DeBoef, professor of chemistry at the University of Rhode Island, and Alcinous Pharmaceutical team members Nicholas DaSilva, CEO and Ph.D. student in the URI College of Pharmacy; Benjamin Barlock, chief technology officer and Ph.D. student in the URI College of Pharmacy; David Worthen, chief operations officer and URI assistant professor in the Department of Biomedical and Pharmaceutical Sciences and the Department of Chemical Engineering; and Ken Rose, chief scientific officer and Ph.D. student in the URI College of Pharmacy, discuss Alcinous’ latest research project. / PBN PHOTO/RUPERT WHITELEY

Alcinous to use $50K Innovation Voucher to create new PARP inhibitor

Education 12/08/2017

Five weeks prior to celebrating its first year in business, Alcinous Pharmaceuticals received a $50,000 Innovation Voucher from R.I. Commerce Corp. The microcompany had been...

- Featured Event -

Latest News

Rhode Island lands $18M in federal grants for AI literacy programs

08/14/2026

R.I. accepting applications for new Workforce Pell Grant program

08/14/2026

Mike Tyson’s cannabis brand launches in Rhode Island

08/14/2026

SEC filing of the week: Pangaea Logistics Solutions posts $10.2M Q2...

08/14/2026

DONALD MCCORMACK, senior consultant to McLaughlin Research Corp., has been elected chairperson of the Undersea Technology Innovation Consortium board of directors. / COURTESY UNDERSEA TECHNOLOGY INNOVATION CONSORTIUM

McCormack elected chair of UTIC board of directors, replacing Proffitt

08/14/2026

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.